$968.6 Million Spirulina Market by Distribution Channel, Product Type, Application - Global Forecast to 2028 - ResearchAndMarkets.com

2022-05-28 02:38:29 By : Mr. Cai Jack

DUBLIN, July 20, 2021--(BUSINESS WIRE)--The "Spirulina Market by Distribution Channel, Product Type, Application - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The spirulina market is expected to record a CAGR of 13.2% from 2021 to 2028 to reach $968.6 million by 2028. In terms of volume, the spirulina market is expected to register a CAGR of 18.1% from 2021 to 2028 to reach 98,768.5 tons by 2028.

The factors such as growing health & wellness trends and dietary supplements industry; growing demand for natural food colors; increasing vegetarianism; stringent regulations regarding the inclusion of synthetic colors and flavors; growing malnutrition; increasing preference for spirulina sourced products, especially omega-3 fatty acids; growing use of spirulina in aquaculture; growing investments from leading color houses, and increase in number of products that include spirulina as ingredients are driving the growth in the global spirulina market. However, low awareness about the benefits of spirulina and challenges associated with spirulina production is expected to hinder the growth of the global spirulina market to some extent.

The global spirulina market study presents historical market data in terms of values and volumes (2019 and 2020), estimated current data (2021), and forecasts for 2028- by distribution channel (consumer channel, business channel), product type (powder, tablets, capsules, flakes, phycocyanin extract, and frozen spirulina), and application (nutraceuticals, food & beverages, animal feed, cosmetics, and agriculture). The study also evaluates industry competitors and analyzes the market at a regional and country level.

Based on the distribution channel, the spirulina market is mainly segmented into consumer and business channels. In 2021, the business channel segment is estimated to account for the largest share of the overall spirulina market. The largest share of this segment is mainly attributed to the direct purchase of bulk spirulina in large quantities by various manufacturers such as nutraceuticals, food and beverages, and animal feed, among others, for further product development.

Based on the product type, the spirulina market is mainly segmented into powder, tablets, capsules, flakes, phycocyanin extracts, and frozen spirulina. The phycocyanin extracts segment is expected to grow with the fastest CAGR during the forecast period, attributed to factors such as tremendous demand from the food and beverage industry, where it is used as a natural food colorant; growing investment from leading players; and expanding application areas of phycocyanin.

However, the nutraceuticals segment is estimated to account for the largest share of the overall spirulina market in 2021. The largest share of this segment is attributed to the booming nutraceutical sector, growing health concerns of the aging population in various countries, growing desire for natural alternatives to traditional pharmaceutical products, and increased awareness among consumers on the link between nutrition and health.

Based on application, in 2021, the nutraceuticals segment is estimated to account for the largest share of the overall spirulina market. The largest share of this segment is mainly attributed to the booming nutraceutical sector, growing health concerns of the aging population in various countries, growing desire for natural alternatives to traditional pharmaceutical products, and increased awareness among consumers on the link between nutrition and health.

4.2.1. Recommended Daily Dose of Spirulina

4.4.1. List of Key Producers, by Size

4.4.1.2. Small Farmers (2-20 Ton/Year)

4.4.1.3. Large Farmers (20-200 Ton/Year)

4.4.1.4. Very Large Farmers (More than 200 Ton/Year)

4.4.3. List of Some of the Key Buyers

5.2.1. Growing Health & Wellness Trends and Dietary Supplements Industry

5.2.2. Growing Demand for Natural Food Colours

5.2.4. Positive Impact on Environment With Spirulina Cultivation

5.2.5. Strict Regulations Regarding the Inclusion of Synthetic Colors and Flavors

5.2.6. Growing Preference for Spirulina-Sourced Products

5.2.7. Growing Use of Spirulina in Aquaculture

5.2.8. Growing Investments from Natural-Color Manufacturers

5.3.1. Low Awareness of Benefits of Spirulina

5.3.2. Complex Production of Algae Products

5.4.1. Emergence of New Application Areas

5.4.3. Growing Demand for Spirulina from Bio Refineries

5.4.4. Increasing Demand for Fresh/Frozen Spirulina

5.5.1. Adoption of New Production Technologies (Photobioreactors)

6. The Impact of Covid-19 on the Spirulina Market

7. Global Spirulina Market, by Distribution Channel

8. Global Spirulina Market, by Product Type

9. Global Spirulina Market, by Application

10. Global Spirulina Market, by Geography

Far East Microalgae Industries Co., Ltd (FEMICO)

Fuqing King Dnarmsa Spirulina Co.Ltd.

Earthrise Nutritionals, LLC (Part of DIC Corporation)

E.I.D. - Parry (India) Limited

Dongtai City Spirulina Bio-Engineering Co. Ltd.

Yunnan Green A Biological Project Co., Ltd.

Zhejiang Comp Spirulina Co., Ltd.

Ordos Xinyuli Spirulina Industry Group Co., Ltd.

Qingdao Haizhijiao Biotechnology Co., Ltd.

Inner Mongolia Rejuve Biotech Co., Ltd.

Hainan Dic Aisheng Microalgae Co., Ltd.

Zhejiang Binmei Biotechnology Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/ycyjq6

View source version on businesswire.com: https://www.businesswire.com/news/home/20210720005755/en/

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.

Stop investing in mediocre businesses. Buy the best, instead.

Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.

Shareholders in Amazon (NASDAQ: AMZN) beat a rising market on Friday morning, with shares gaining 3% by 10:45 a.m. ET compared to a 1.4% boost in the S&P 500. The rally was powered by a brightening outlook around economic growth and consumer spending. A major factor driving Amazon's stock higher on Friday was the boost in the wider tech world.

Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.

Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.

The market is unstable. Your portfolio doesn’t need to be.

Choosing between two depends on whether you'd rather pay taxes now, or later.

The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.

Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.

Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.

Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th

The stock market is a game of risk and calculation, and in recent months the risks are mounting. The first quarter of 2022 showed a net negative GDP growth rate, a contraction of 1.4%; another contraction in Q2 will indicate a recession. Wall Street’s experts are trying to look ahead, to see through the fog of uncertainty and get some feel for where things are going. Covering the market for Morgan Stanley, chief US equity strategist Michael Wilson believes that we’ll dodge the recession bullet –

Nikola (NASDAQ: NKLA) hasn't posted any significant news since it reported first-quarter earnings earlier this month. Early in Friday's trading session, Nikola shares were 19.6% higher for the week, according to data provided by S&P Global Market Intelligence. More than 20% of Nikola's outstanding shares were sold short, as of mid-May. And because a large number of those shares are held by company executives or in its treasury, 36.5% of Nikola's share float were being shorted by investors, according to MarketWatch.

These two fintechs are generating strong revenue growth, but have been caught up in the market swoon.

Theme parks, streaming services, and multiplexes are hoping the next few months are lucrative, and Walt Disney (NYSE: DIS), Netflix (NASDAQ: NFLX), and AMC Entertainment Holdings (NYSE: AMC) feel that there is no time like the present. A popular series is back with a new season -- part of a new season, anyway -- on Netflix. AMC hopes that the reboot of a classic action franchise will kick off a promising summer season.

Yahoo Finance's Allie Garfinkle joins the Live show to detail what was addressed at Amazon's shareholder meeting, including labor unions, shareholder proposals, and what these shareholder proposals mean.

Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.

Stocks have been inching back in recent days from the brink of bear market territory. It may be time to scoop up shares at steep discounts.